EU reaches virus vaccine deal with CureVac

coronavirus
Credit: CC0 Public Domain

The EU said Thursday it has concluded talks with German pharmaceutical firm CureVac, aiming to secure 225 million doses of a potential coronavirus vaccine.

It is the fourth agreement the bloc has reached with companies working on a potential vaccine against the , after deals with Sanofi-GSK, Johnson and Johnson and AstraZeneca.

"The envisaged contract with CureVac would provide for the possibility for all EU member states to purchase the vaccine," the European Commission, the bloc's executive arm, said in a statement.

An agreement to buy the vaccine will come once it has been shown to be safe and effective, the commission said.


Explore further

Follow the latest news on the coronavirus (COVID-19) outbreak

© 2020 AFP

Citation: EU reaches virus vaccine deal with CureVac (2020, August 20) retrieved 24 October 2020 from https://medicalxpress.com/news/2020-08-eu-virus-vaccine-curevac.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
4 shares

Feedback to editors

User comments